Saphetor

📍 Lausanne, Switzerland🗓 Founded 2014👥 65 employees💰 Last funded 2019
Biotechnology Research🌐 saphetor.com
Website LinkedIn
Saphetor SA, is a global precision-medicine company dedicated to large-scale identification and interpretation of human genetic variants by leveraging proprietary algorithms and expert domain knowledge. Saphetor is the creator of VarSome, a suite of intuitive and data-driven bioinformatics solutions for clinicians and researchers. VarSome is powered by a Molecular DB with over 130 integrated and harmonized genomic data sources, linked by AI to over 32 million publications. Thanks to VarSome’s global community of over 450 000, the database is further enriched by additional unique user-generated annotation. Saphetor has developed proprietary algorithms to automate variant classification based on industry-standard ACMG and AMP guidelines for interpretation of germline and somatic variants, as well as CNVs. The VarSome suite offers solutions for individuals needing a powerful Search tool to support research, professional labs requiring a CE-IVD and HIPPA-compliant platform to Analyze NGS samples, and bioinformaticians wanting to use our simple API to access our database and classifiers and integrate into existing Code.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Saphetor?
Saphetor has 1 investors on record on gritt.io, 1 mid-stage.
When did Saphetor last raise funding?
The most recent investment in Saphetor recorded on gritt.io was in 2019.
When was Saphetor founded?
Saphetor was founded in 2014.
What industry is Saphetor in?
Saphetor operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Saphetor based?
Saphetor is headquartered in Lausanne, Switzerland.